Cahn, A., Raz, I., Bonaca, M., Mosenzon, O., Murphy, S. A., Yanuv, I., Rozenberg, A., Wilding, J. P. H., Bhatt, D. L., McGuire, D. K., Gause‐Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Jermendy, G., Hadjadj, S., Langkilde, A. M., Sabatine, M. S., Wiviott, S. D., & Leiter, L. A. (2020). safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study. Diabetes, obesity & metabolism, 22(8), 1357–1368. http://access.bl.uk/ark:/81055/vdc_100103804643.0x00001d